Skip to main content
. 2008 Apr 14;154(2):429–439. doi: 10.1038/bjp.2008.95

Figure 7.

Figure 7

Effects of protein kinase C (PKC) inhibitors and activators on the response of the rapid component of IK (IKr) to angiotensin II (Ang II; 100 nM). (a and b) Effects of (a) the nonspecific PKC inhibitor, staurosporin (Stau; 100 nM) and (b) the specific PKC inhibitor, Bis-1 (300 nM), on the inhibition of IKr tail current by Ang II. (c) A summary of the data expressed as a percentage of decrease of IKr tail current by Ang II in the presence of Stau or Bis-1. (d and e) Effects of the PKC activators (d) PMA (100 nM) and (e) PdBu (100 nM), on the inhibition of IKr tail current by Ang II. (f) A summary of the data expressed as a percentage of decrease of IKr tail current by Ang II in the presence of PMA or PdBu. The amplitude of the IKr tail currents was measured using the same pulse protocol described in Figure 5. IK, the delayed rectifier K+ currents.